Edward Stelmakh

Edward Stelmakh

Chief Financial & Strategy OfficeratOptimizeRx· In proxies 2022–2025

Pay in FY2025+51% from the year before · OptimizeRx stock +152.3% the same year

Edward Stelmakh was paid $1.5M in FY2025 (Dec), up 51%. OptimizeRx stock rose 152.3% that year.

Pay$100 in the stock at the end of FY21 → $20
Pay is from the Summary Compensation Table of each OptimizeRx proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. OptimizeRxPublic company · 4 yr
    • Chief Financial & Strategy Officer2022 – Present · 4 yrStock in role -85%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?